Summary Overview

Of all 21 industries represented in the 2020 China Business Climate Survey results, AmCham China members from the healthcare products (e.g., pharmaceuticals, medical devices) industry report the second-highest level of profitability for 2019. However, the industry also faces unique problems in intellectual property protection that will not improve without significant changes to the Chinese regulatory environment.

This 40-page report explores the insights and implications for the healthcare products industry drawn from the industry-specific data of the 2020 BCS Report.

Across its 40 data-driven pages, the report focuses on six main areas, including:

  • Executive Summary
  • 2019 Performance Snapshot
  • Business Climate Challenges and Investment Outlook
  • Regulatory Environment
  • Innovation
  • Policy Perspectives

This industry report is free for all members. If you are an AmCham China member and would like access to this report, please email If you are not yet a member and would like to get access to all 16 industry reports, plus many other benefits, please contact our Membership team at

For non-members, this report can be purchased for 350 RMB. To purchase this report, click the button below.